Vaccines for children FY25
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30125D00195
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- 75D30125R00065 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $4,382,496,700.00
- Maximum order
- $4,382,496,700.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The CDC Pittsburgh awarded a multiple-award indefinite delivery contract to Merck Sharp & Dohme LLC for pediatric vaccine procurement under the Vaccines for Children program, with a ceiling of $4.38 billion and an award date of April 1, 2025.
The contract extends from April 1, 2025 through March 31, 2026, with options through March 31, 2026. No set-aside was used. Performance occurs at locations supporting federal vaccine distribution to state and local immunization programs, consistent with VFC program requirements for pediatric vaccine supply.
The solicitation called for indefinite-quantity delivery of CDC-approved pediatric vaccines for distribution to federally qualified health centers, rural health clinics, and state immunization programs. The VFC program ensures vaccine access to uninsured, underinsured, and American Indian/Alaska Native children.
This is one of multiple awards under the Vaccines for Children program. Merck also holds a separate $66.01 million adult vaccines indefinite delivery contract with the CDC, awarded July 1, 2025 and extending through June 30, 2026, reflecting the CDC's multi-vendor vaccine procurement strategy. The pediatric VFC contract represents one of the agency's cornerstone vaccine supply vehicles, anchoring Merck's federal footprint with the CDC Pittsburgh, which accounts for 31 awards totaling $43.36 billion in combined potential value across Merck's full federal portfolio.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$53,817,332 | |
| Funding Only Action | $273,479,581 | |
| Funding Only Action | $251,833,641 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $87,324,965 | |
| Supplemental Agreement for work within scope | $155,705,000 | |
| Funding Only Action | $628,502,701 | |
| Other Administrative Action | $513,089,616 | |
| Funding Only Action | $551,586,668 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75D30125D00195?
75D30125D00195 was awarded to Merck Sharp & Dohme LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 1, 2025.
How much is contract 75D30125D00195 worth?
75D30125D00195's own ceiling is $4,382,496,700. A single order can be worth up to $4,382,496,700.
Who can order from contract 75D30125D00195?
75D30125D00195 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30125D00195 competed?
The extent of competition for 75D30125D00195 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV